0: Pharmacotherapy for leishmaniasis treatment and Chagas disease is a little bit scarce ( 4).
1: This is due to commercial disinterest reflected by the fact that the parasitic diseases mainly affect developing countries, where the population has low purchasing power, leading to a low yield for factories, because the drugs would have to be affordable ( 5).
